9AT: ECOR1 CAPITAL, LLC

other names

ECOR1 CAPITAL, LLC

Adviser Profile

As of Date	03/30/2026
ADV Location	SAN FRANCISCO, CA, United States
Adviser Type - Large advisory firm
Number of Employees	22 5%
of those in investment advisory functions	9 13%
Registration	SEC, Approved, 07/02/2015
Other registrations (2)	SEC, ERA - Withdrawn, 06/29/2015 California, ERA - Withdrawn, 06/29/2015

AUM^*	3,424,668,843 -32%
of that, discretionary	3,424,668,843 -32%
Private Fund GAV^*	3,424,668,843 -13%
Avg Account Size	684,933,769 -32%
SMA’s	No
Private Funds	5
Contact Info	415 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Fund Type	Count	GAV
Fund TypeHedge Fund	Count3	GAV$3,359,232,831
Fund TypeVenture Capital Fund	Count2	GAV$65,436,012

Adviser	Hedge Fund	Liquidity Fund	Private Equity Fund	Real Estate Fund	Securitized Asset Fund	Venture Capital Fund	Other Fund	Total Private Fund GAV	AUM	#Funds
Adviser SAGE MOUNTAIN ADVISORS, LLC	Hedge Fund24.7m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund6.4m	Other Fund-	Total Private Fund GAV37.4m	AUM4.3b	#Funds3
Adviser GLOBAL FRONTIER INVESTMENTS, LLC	Hedge Fund30.2m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund74.0m	Other Fund-	Total Private Fund GAV178.1m	AUM682.0m	#Funds3
Adviser LIVIAN & CO.	Hedge Fund4.5m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund431.0k	Other Fund-	Total Private Fund GAV5.4m	AUM152.9m	#Funds3
Adviser MIG CAPITAL, LLC	Hedge Fund589.5m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV589.5m	AUM589.5m	#Funds3
Adviser CORAL CAPITAL MANAGEMENT LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund-	Other Fund-	Total Private Fund GAV-	AUM-	#Funds-
Adviser ZILKHA INVESTMENTS, L.P.	Hedge Fund65.6m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund2.5m	Other Fund-	Total Private Fund GAV70.6m	AUM-	#Funds3
Adviser PANTERA CAPITAL	Hedge Fund3.8b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund794.9m	Other Fund-	Total Private Fund GAV5.4b	AUM4.0b	#Funds45
Adviser ARCA INVESTMENT MANAGEMENT, LLC	Hedge Fund223.5m	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund65.2m	Other Fund-	Total Private Fund GAV354.0m	AUM188.1m	#Funds11
Adviser MIO PARTNERS, INC.	Hedge Fund27.8b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund156.0m	Other Fund-	Total Private Fund GAV28.1b	AUM59.6b	#Funds15
Adviser AWM INVESTMENT COMPANY INC	Hedge Fund1.3b	Liquidity Fund-	Private Equity Fund-	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund8.3m	Other Fund-	Total Private Fund GAV1.3b	AUM1.3b	#Funds9

Stock Ticker	Stock Name	$ Position	% Position	$ Change	# Change
Stck Ticker98985Y108	Stock NameZYMEWORKS INC	$ Position$604,810,316	% Position27.00%	$ Change54.00%	# Change0.00%
Stck Ticker032724106	Stock NameANAPTYSBIO INC	$ Position$382,026,957	% Position17.00%	$ Change58.00%	# Change0.00%
Stck TickerG50871105	Stock NameJAZZ PHARMACEUTICALS PLC	$ Position$290,099,730	% Position13.00%	$ Change29.00%	# Change0.00%
Stck Ticker22663K107	Stock NameCRINETICS PHARMACEUTICALS IN	$ Position$199,611,986	% Position9.00%	$ Change12.00%	# Change0.00%
Stck Ticker152309100	Stock NameCENTESSA PHARMACEUTICALS PLC	$ Position$77,906,150	% Position4.00%	$ Change484.00%	# Change466.00%
Stck Ticker55287L101	Stock NameMBX BIOSCIENCES INC	$ Position$66,978,470	% Position3.00%	$ Change80.00%	# Change0.00%
Stck TickerH17182108	Stock NameCRISPR THERAPEUTICS AG	$ Position$72,853,633	% Position3.00%	$ Change-19.00%	# Change0.00%
Stck Ticker45257U108	Stock NameIMMUNOME INC	$ Position$61,338,073	% Position3.00%	$ Change28.00%	# Change-30.00%
Stck Ticker68622P109	Stock NameORIC PHARMACEUTICALS INC	$ Position$55,035,989	% Position2.00%	$ Change-32.00%	# Change0.00%
Stck Ticker98401F105	Stock NameXENCOR INC	$ Position$49,774,525	% Position2.00%	$ Change-31.00%	# Change-47.00%

Brochure Summary

Overview

EcoR1 Capital, LLC (“EcoR1”) is a limited liability company that has been in business since 2012. EcoR1’s manager, controlling owner and portfolio manager is Oleg Nodelman. As of December 31, 2023, EcoR1 had total discretionary net assets under management of approximately $3.858 billion. EcoR1 only manages assets on a discretionary basis. EcoR1 serves as the general partner of and investment adviser to the EcoR1 Capital Funds (the “Capital Funds”), which invest principally, but not solely, in equity and equity-related securities that are issued by biotechnology companies and traded publicly in U.S. and non-U.S. markets. The Capital Funds also invest in illiquid securities (generally, restricted securities of public and private companies). EcoR1 also serves as the investment adviser to the EcoR1 Venture Opportunity Funds (the “Venture Funds”), which invest principally, but not solely, in restricted equity and equity-related securities issued by privately-held biotechnology companies globally. EcoR1 intends to allocate investment opportunities in such restricted securities between the Capital Funds and the Venture Funds as described in each fund’s offering materials. In the future, EcoR1 may, but is not required to, offer one or more

investors in its funds or clients (or any other persons) the right to participate in investments in which the Capital Funds or the Venture Funds participate if (a) EcoR1 believes that such participation would benefit those funds or the portfolio company or (b) EcoR1 determines that those funds have been allocated the full amount of such investment in the portfolio company in light of their risk-return profiles, available capital and other considerations EcoR1 determines to be relevant. Any such fund that may be established in the future is called an “SPV” and collectively, the “SPVs.” The Capital Funds, the Venture Funds and the SPVs are collectively referred to herein as “clients” or “funds.” EcoR1 selects all fund investments and strategies. While the offering documents for each fund describes the specific investment strategy that EcoR1 intends to follow for that fund, EcoR1 is generally authorized to enter into any type of investment transaction that it deems appropriate under the terms of the applicable fund’s or client account’s governing documents. The investors in the funds that EcoR1 manages have no opportunity to select or evaluate any fund investments or strategies. EcoR1 does not participate in wrap fee programs.

ECOR1 CAPITAL, LLC

Adviser Profile

Details

Client Types

Advisory Activities

Compensation Arrangments

Reported AUM

Private Funds

Employees

Private Funds Structure

Similar advisers

Top Holdings

Brochure Summary

Overview